Syllabus PAOKC-cursus Klinische Chemie en ... - NVKC

Literatuur
1. Rodgers RP, Levin J.
A critical reappraisal of the bleeding time.
Semin Thromb Hemost. 1990;16(1):1-20.
2. Watala C, Golanski J, Rozalski M, Boncler MA, Luzak B, Baraniak J,
Korczynski D, Drygas W.
Is platelet aggregation a more important contributor than platelet
adhesion to the overall platelet-related primary haemostasis measured
by PFA-100?
Thromb Res. 2003;109(5-6):299-306.
3. Veyradier A, Fressinaud E, Meyer D.
Laboratory diagnosis of von Willebrand disease.
Int J Clin Lab Res. 1998;28(4):201-10
4. Kerenyi A, Schlammadinger A, Ajzner E, Szegedi I, Kiss C, Pap Z, Boda
Z, Muszbek L. Comparison of PFA-100 closure time and template
bleeding time of patients with inherited disorders causing defective
platelet function.
Thromb Res. 1999;96(6):487-92.
5. Posan E, McBane RD, Grill DE, Motsko CL, Nichols WL.
Comparison of PFA-100 testing and bleeding time for detecting platelet
hypofunction and von Willebrand disease in clinical practice.
Thromb Haemost. 2003;90(3):483-90.
6. Cariappa R, Wilhite TR, Parvin CA, Luchtman-Jones L.
Comparison of PFA-100 and bleeding time testing in pediatric patients
with suspected hemorrhagic problems.
J Pediatr Hematol Oncol. 2003;25(6):474-9.
7. Chakroun T, Gerotziafas G, Robert F, Lecrubier C, Samama MM, Hatmi
M, Elalamy I.
In vitro aspirin resistance detected by PFA-100 closure time: pivotal role
of plasma von Willebrand factor.
Br J Haematol. 2004;124(1):80-5.
8. Fattorutto M,Pradier O,Schmartz D,Ickx B,Barvais L.
Does the platelet function analyser (PFA-100) predict blood loss after
cardiopulmonary bypass?
Br J Anaesth. 2003;90(5):692-93.
9